Published on in Vol 8, No 1 (2022): Jan-Mar
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/32291, first published
.
Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non–Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process
Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non–Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process
Journals
- Rutz J, Maxeiner S, Grein T, Sonnenburg M, Khadir S, Makhatelashvili N, Mann J, Xie H, Cinatl J, Thomas A, Chun F, Haferkamp A, Blaheta R, Tsaur I. Allyl-, Butyl- and Phenylethyl-Isothiocyanate Modulate Akt–mTOR and Cyclin–CDK Signaling in Gemcitabine- and Cisplatin-Resistant Bladder Cancer Cell Lines. International Journal of Molecular Sciences 2022;23(19):10996 View
- Nishikawa S, Iwakuma T. Drugs Targeting p53 Mutations with FDA Approval and in Clinical Trials. Cancers 2023;15(2):429 View
- Wang Z, Kwan M, Haque R, Goniewicz M, Pratt R, Lee V, Roh J, Ergas I, Cannavale K, Loo R, Aaronson D, Quesenberry C, Zhang Y, Ambrosone C, Kushi L, Tang L. Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non–muscle-invasive bladder cancer: findings from the Be-Well Study. The American Journal of Clinical Nutrition 2023;117(6):1110 View
- Shih Y, Hsu S, Lai K, Chueh F, Huang Y, Kuo C, Chen Y, Chen C, Peng S, Huang W, Lu H. Allyl isothiocyanate induces DNA damage and inhibits DNA repair‐associated proteins in a human gastric cancer cells in vitro. Environmental Toxicology 2023 View